Thompson Siegel & Walmsley’s Anterix ATEX Stock Holding History

Thompson Siegel & Walmsley’s Portfolio ATEX Stock Details ATEX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-18,534	Closed	-$612K	–	535
2023 Q1	$612K	Buy	18,534 +5,990	+48%	+$196K	0.01%	291
2022 Q4	$404K	Buy	12,544 +9,310	+288%	+$317K	0.01%	300
2022 Q3	$116K	Buy	+3,234	New	+$134K	﹤0.01%	381
2022 Q1	–	Sell	-28	Closed	-$2K	–	634
2021 Q4	$2K	Sell	28 -442	-94%	-$26.8K	﹤0.01%	601
2021 Q3	$29K	Sell	470 -60,285	-99%	-$3.53M	﹤0.01%	537
2021 Q2	$3.65M	Sell	60,755 -19,358	-24%	-$970K	0.05%	205
2021 Q1	$3.78M	Buy	+80,113	New	+$3.3M	0.05%	187

Other funds holding ATEX

OCAM

Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return

HCL

Heard Capital LLC Chicago, Illinois $1.93B AUM 21.66% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Stonehill Capital Management New York $197M AUM 96.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JCP

Jennifer C. Price $75.5M AUM 6.25% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Thompson Siegel & Walmsley's ATEX Position: Q2 2023 in Review

Thompson Siegel & Walmsley sold out of Anterix (ATEX) in Q2 2023, closing a stake of 18,534 shares — an estimated $612K sold.

Thompson Siegel & Walmsley first reported a position in ATEX in Q1 2021 and held it in 7 quarters. The position peaked at $3.78M in Q1 2021. 95 funds tracked by Wall St. Rank hold ATEX as of Q2 2023.

Thompson Siegel & Walmsley reported no remaining Anterix position as of Q2 2023 after selling out during the quarter.
Thompson Siegel & Walmsley sold 18,534 Anterix shares in Q2 2023, an estimated $612K.
Thompson Siegel & Walmsley first reported a position in Anterix in Q1 2021 and held it in 7 quarters.
Thompson Siegel & Walmsley's Anterix position peaked at $3.78M in Q1 2021.
95 funds tracked by Wall St. Rank held Anterix as of Q2 2023.

Based on Thompson Siegel & Walmsley's 13F filing for Q2 2023, filed 10 Aug 2023.